In addition, miR-34a was found to affect the expression of cancer stem cells (CSCs) overexpressing CD44, leading to tumorigenesis and recurrence, while inhibiting the proliferation, metastasis, and survival of CD44-positive CSCs (Jang et al., 2016). This evidence concerns the gene CD44 and cancer.